Small Cap Research: Cytosorbents (CTSO) a Rapidly Growing Blood Purification Treatment Co. May 13, 2018 Cytosorbents (CTSO) is a $241M Company focused on blood purification technology for preventing and treating multiple organ failure. Its main product CytoSorb is utilized in... read more